BiomeSense
PrivateLast Round
Grant
Jun 16, 2026
Est. Valuation
$16.71M
Total Funding Raised
$14.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
BiomeSense operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was a Grant round in June 2026.
BiomeSense is a healthtech company that provides an integrated precision measurement and analytics platform designed to transform microbiome data generation and analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BiomeSense Comparables
Compare BiomeSense with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Intus Bio | 74% | |
| Cosmos-Hub | 73% | |
| BiomeHub | 68% |
For institutional investors. Book with your work email.
BiomeSense Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 16, 2026 | ||||
| Seed | Oct 21, 2025 | ||||
| Grant | Mar 15, 2024 | ||||
| Seed | May 18, 2023 | ||||
| Seed | Oct 7, 2019 | ||||
Accelerator | Mar 28, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BiomeSense Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioX Clan | Seed |
| Seaside Ventures | Seed |
| Bluestein Ventures | Seed |
| Shorewind Capital | Seed |
| National Institutes of Health (NIH) | Grant |
| SOSV | Seed, Accelerator |
| Polsky Center for Entrepreneurship and Innovation at the University of Chicago | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open roles increased to 36, 200% of current headcount.
- Jun 16, 2026
$677K grant received from the National Institutes of Health.
For institutional investors. Book with your work email.
BiomeSense Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BiomeSense's valuation, stock price, and market status.
Is BiomeSense a public or private company?
BiomeSense is a private company.
What is the current stock price of BiomeSense?
BiomeSense is a private company, so its shares have no public market price. Caplight tracks BiomeSense's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BiomeSense worth (valuation)?
BiomeSense's valuation is estimated at $16.7M based on funding round data.
Can I buy BiomeSense stock?
BiomeSense shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BiomeSense's last funding round?
BiomeSense's most recent funding round was Grant on June 16, 2026.
Who are the main investors in BiomeSense?
Key investors in BiomeSense include BioX Clan, Bluestein Ventures.
Will BiomeSense IPO soon?
No public IPO plans have been announced for BiomeSense.
How can I track BiomeSense secondary market activity?
Caplight tracks bids, offers, and trades in BiomeSense's shares on secondary markets.